Kitsiou-Tzeli Sophia, Papadopoulou Anna, Kanaka-Gantenbein Christina, Fretzayas Andreas, Daskalopoulos Dimitris, Kanavakis Emmanuel, Nicolaidou Polyxeni
Department of Medical Genetics, University of Athens, Aghia Sophia Children's Hospital, Thivon & Levadias, Goudi, Athens, Greece.
Horm Res. 2006;66(3):124-31. doi: 10.1159/000094145. Epub 2006 Jun 23.
Noonan syndrome NS (OMIM 163950) is an autosomal dominant developmental disorder characterized mainly by typical facial dysmorphism, growth retardation and variable congenital heart defects. In unrelated individuals with sporadic or familial NS, heterozygous missense point mutations in the gene PTPN11 (OMIM 176876) have been confirmed, with a clustering of mutations in exons 3 and 8, the mutation A922G Asn308Asp accounting for nearly 25% of cases.
We report a 7-year-old boy with short stature and some other clinical features of NS, who has been investigated by molecular analysis for the presence of mutations in the PTPN11 gene.
The de novo mutation A172G in the exon 3 of the PTPN11 gene, predicting an Asn58Asp substitution, has been found. To the best of our knowledge, this specific mutation has only been described once before, but this is the first report of detailed clinical data suggesting a mild phenotype.
Detailed clinical phenotype in every patient with major or minor features of NS and molecular identification of PTPN11 gene mutation may contribute to a better phenotype-genotype correlation.
努南综合征(NS,OMIM 163950)是一种常染色体显性发育障碍,主要特征为典型的面部畸形、生长发育迟缓以及多种先天性心脏缺陷。在散发性或家族性NS的非亲缘个体中,已证实基因PTPN11(OMIM 176876)存在杂合错义点突变,外显子3和8存在突变聚集现象,其中A922G(Asn308Asp)突变占近25%的病例。
我们报告一名7岁男孩,有身材矮小及NS的其他一些临床特征,已通过分子分析对PTPN11基因中的突变情况进行了研究。
发现PTPN11基因外显子3中的新发突变A172G,预测为Asn58Asp替代。据我们所知,这种特定突变此前仅被描述过一次,但这是首次报告提示轻度表型的详细临床数据。
对具有NS主要或次要特征的每位患者进行详细的临床表型分析以及对PTPN11基因突变进行分子鉴定,可能有助于更好地建立表型-基因型相关性。